Single-step identification of all length polymorphisms in the UGT1A1 gene promoter

International Journal of Clinical Pharmacology and Therapeutics

Volumn 42, Issue 3, 2004, Pages 133-138

  Skarke, C ^a   Grosch S ^a   Geisslinger, G ^a   Lotsch J ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Gilbert's syndrome; Pharmacogenetics; Pyrosequencing

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE; INDINAVIR; IRINOTECAN; PARACETAMOL;

ALLELE; ARTICLE; BILIRUBIN BLOOD LEVEL; DNA TEMPLATE; DOSE CALCULATION; DRUG METABOLISM; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; GILBERT DISEASE; HOMOZYGOSITY; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN POLYMORPHISM; RELIABILITY; SENSITIVITY ANALYSIS;

EID: 2442555967     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP42133     Document Type: Article

References (28)

1. Akaba K, Kimura T, Sasaki A, Tanabe S, Ikegami T, Hashimoto M, Umeda H, Yoshida H, Umetsu K, Chiba H, Yuasa I, Hayasaka K 1998 Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyltransferase gene: a common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 46: 21-26
2. Alderborn A, Kristofferson A, Hammerling U 2000 Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 10: 1249-1258
3. Ando Y, Saka H, Asai G, Sugiura S, Shimokata K, Kamataki T 1998 UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan. Ann Oncol 9: 845-847
4. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y 2000 Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60: 6921-6926
5. Aono S, Adachi Y, Uyama E, Yamada Y, Keino H, Nanno T, Koiwai O, Sato H 1995 Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome. Lancet 345: 958-959
6. Beutler E, Gelbart T, Demina A 1998 Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 95: 8170-8174
7. Borlak J, Thum T, Landt O, Erb K, Hermann R 2000 Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects. Hepatology 32: 792-795.
8. Bosma P, Chowdhury JR, Jansen PH 1995a Genetic inheritance of Gilbert's syndrome. Lancet 346: 314-315
9. Bosma P, Chowdhury JR, Bakker C, Gantla S, de Boer A, Oostra BA, Lindhout D, Tytgat GN, Jansen PL, Oude Elferink RP et al 1995b The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333: 1171-1175
10. Burchell B, Brierley CH, Monaghan G, Clarke DJ 1998 The structure and function of the UDP-glucuronosyltransferase gene family. Adv Pharmacol 42: 335-338
11. Burchell B, Hume R 1999 Moleculargenetic basis of Gilbert's syndrome. J Gastroenterol Hepatol 14: 960-966
12. Court MH, Duan SX, von Moltke LL, Greenblatt DJ, Patten CJ, Miners JO, Mackenzie PI 2001 Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransfemse isoforms. J Pharmacol Exp Ther 299: 998-1006
13. Esteban Rodriguez A, Perez-Mateo Regadera M 1999 The heterogeneity of paracetamol metabolism in Gilbert's disease. Gastroenterol Hepatol 22: 265-269
14. Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC 2001 Thirteen UDP-glucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics 11: 357-368
15. 8 allele in the UGT1A1 gene promoter of a Caucasian with Gilbert's yndrome. Hematologica 84: 106-109
16. Iyer L, Hall D, Das S, Mortell MA, Ramirez J, Kim S, Di Rienzo A, Ratain MJ 1999 Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin Pharmacol Ther 65: 576-582
17. Koiwai O, Nishizawa M, Hasada K, Aono S, Adachi Y, Mamiya N, Sato H 1995 Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase. Hum Mol Genet 4: 1183-1186
18. Martin-Escudero JC, Duenas-Laita A, Perez- Castrillon JL, Herreros-Fernandez V 2003 Olanzapine toxicity in unconjugated hyperbilirubinaemia (Gilbert's syndrome). Br J Psychiatry 182: 267
19. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B 1996 Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 347: 578-581
20. Nyren P, Lundin A 1985 Enzymatic method for continuous monitoring of inorganic pyrophosphate synthesis. Anal Biochem 151: 504-509
21. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P 1996 Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242: 84-89
22. Ronaghi M, Uhlen M, Nyren P 1998 A sequencing method based on real-time pyrophosphate. Science 281: 363-365
23. Skarke C, Schmidt H, Geisslinger G, Darimont J, Lotsch J 2003 Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome. Br J Clin Pharmacol 56: 228-231
24. Tsezou A, Tzetis M, Kitsiou S, Kavazarakis E, Galla A, Kanavakis E 2000 A Caucasian boy with Gilbert's syndrome heterozygous for the (TA)(8) allele. Hematologica 85: 319
25. von Ahsen N, Oellerich M, Schutz E 2000 DNA base bulge vs unmatched end formation in probe-based diagnostic insertion/deletion genotyping: genotyping the UGT1A1 (TA)(n) polymorphism by real-time fluorescence PCR. Clin Chem 46: 1939-1945
26. Wasserman E, Myara A, Lokiec F, Goldwasser F, Trivin F, Mahjoubi M, Misset JL, Cvitkovic E 1997 Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports. Ann Oncol 8: 1049-1051
27. Wittwer CT, Ririe KM, Andrew RV, David DA, Gundry RA, Balis UJ 1997 The LightCycler: a microvolume multisample fluorimeter with rapid temperature control. Biotechniques 22: 176-181
28. Zucker SD, Qin X, Rouster SD, Yu F, Green RM, Keshavan P, Feinberg J, Sherman KE 2001 Mechanism of indinavir-induced hyperbilirubinemia. Proc Natl Acad Sci USA 98: 12671-12676